Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use DisorderBohdan Nosyk, M. Eugenia Socías, Mohammad Ehsanul Karim et al.|JAMA|2024Cited by 60
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment ReceiptJeong Eun Min, Bohdan Nosyk, Brenda Carolina Guerra‐Alejos et al.|JAMA Network Open|2024Cited by 14
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, CanadaRuyu Yan, Bohdan Nosyk, Megan Kurz et al.|BMJ Open|2024Cited by 2
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, CanadaRuyu Yan, Bohdan Nosyk, Md. Belal Hossain et al.|BMJ Open|2025Cited by 2
Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational studyMegan Kurz, Bohdan Nosyk, Brenda Carolina Guerra‐Alejos et al.|BMJ Open|2025Cited by 1